deCODE genetics has announced its acquisition of privately-held Icelandic cancer research firm Urdur, Verdandi Skuld (UVS). The acquisition enables deCODE to broaden and enhance its cancer program by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results